Clinical Trials in Austin

Showing 12161-12180 of 15,205 trials

AqueSys Microfistula Implant in Refractory Glaucoma

NCT01640756

To establish the safety and performance of the AqueSys Microfistula Implant in eyes with refractory glaucoma.

AqueSys, Inc.60 participantsStarted Jul 2012

Fayetteville, Arkansas, United States • Los Angeles, California, United States • San Diego, California, United States +11 more locations

COMPLETEDNA< 1 mile

Exercise and Virtual Reality Exposure Therapy for Acrophobia

NCT02361203

The purpose of this study is to determine whether aerobic exercise can enhance the effects of exposure therapy treatment for fear of heights.

Fear of Heights

University of Texas at Austin60 participantsStarted Feb 2015

Austin, Texas, United States

COMPLETEDPhase 174 miles

A Study of Administration of Peginterferon Alfa-2a [Pegasys] by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C

NCT01087944

This randomized, cross-over, open label study will compare the tolerability and handling of application of peginterferon alfa-2a \[Pegasys\] by autoinjector versus pre-filled syringe in patients with chronic hepatitis C, either on treatment with peginterferon alfa-2a for at least 12 weeks or treatment-naïve for peginterferon alfa-2a. Patients will be randomized to self-injection of 180mcg peginterferon alfa-2a once a week using either an autoinjector or a prefilled syringe for 3 weeks, then switch to use the other method of injection for another 3 weeks. Anticipated time on study treatment is 6 weeks. Target sample size is \<100 patients.

Hepatitis C, Chronic

Hoffmann-La Roche60 participantsStarted Mar 2010

Los Angeles, California, United States • Bradenton, Florida, United States • Orlando, Florida, United States +9 more locations

AqueSys Microfistula Implant in Refractory Glaucoma

Exercise and Virtual Reality Exposure Therapy for Acrophobia

A Study of Administration of Peginterferon Alfa-2a [Pegasys] by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C

Find Trials by Condition in Austin

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

TearLab Refractive Surgery Dry Eye Study

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease

NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)

Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome

Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation

First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)

Safety and Efficacy the Medigus SRS Endoscopic Stapling System in Gastroesophageal Reflux Disease (GERD)